Effect of extracorporeal shock wave therapy for burn scar regeneration: A prospective, randomized, double-blinded study.

Burns

Department of Rehabilitation Medicine, Hangang Sacred Heart Hospital, College of Medicine, Hallym University, Seoul, Republic of Korea. Electronic address:

Published: June 2021

AI Article Synopsis

  • This study explored the effectiveness of extracorporeal shock wave therapy (ESWT) in improving hypertrophic scar regeneration after skin grafting through a double-blind, randomized trial with 48 participants.
  • Results indicated that the ESWT group showed significant improvements in scar thickness and erythema compared to the control group, as well as increased sebum levels, while no significant differences were found in melanin levels or skin elasticity.
  • The findings suggest ESWT has beneficial effects on the characteristics of burn-related scars, marking it as the first study to utilize objective measurement tools in this context.

Article Abstract

Purpose: This study aimed to investigate the regeneration effect of extracorporeal shock wave therapy (ESWT) on hypertrophic scar regeneration using objective measurements.

Methods: This was a double-blinded, randomized, controlled trial of 48 participants who had undergone autologous split-thickness skin grafting (STSG) with same artificial dermis. The ESWT group (n=25) received shock waves with low-energy flux density (0.05-0.30mJ/mm). The interval between treatments is a 1-week. The ESWT group also received recommended treatment. The control group (n=23) only received standard treatment. We measured skin characteristics before treatment and after 6 weeks for both groups.

Results: No significant intergroup difference was noted at the initial evaluations (p>0.05). The pre- to post-treatment change in the scar thickness (p=0.03) and erythema (p=0.03), greater reduction was found in the ESWT group than control group. The pre- to post-treatment change in the sebum level (p=0.02), more increase was found in the ESWT group. We found no significant differences in the change measurements between the two groups for melanin levels (p=0.62) and transepidermal water loss (TEWL) (p=0.94). The changes (skin distensibility, biological skin elasticity, gross skin elasticity, and skin viscoelasticity) measured with the Cutometer showed no significant differences between the two groups (p=0.87, p=0.32, p=0.37, and p=0.29, respectively).

Conclusion: This is the first report of ESWT on hypertrophic scar after burn using objective tools (melanin, erythema, sebum, TEWL, elasticity and thickness). ESWT has objective beneficial effects on burn-associated scar characteristics.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.burns.2020.08.009DOI Listing

Publication Analysis

Top Keywords

eswt group
16
extracorporeal shock
8
shock wave
8
wave therapy
8
scar regeneration
8
eswt hypertrophic
8
hypertrophic scar
8
control group
8
pre- post-treatment
8
post-treatment change
8

Similar Publications

Osteoporosis (OP) is a chronic inflammatory bone disease characterized by reduced bone structure and strength, leading to increased fracture risk. Effective therapies targeting both bone and cartilage are limited. This study compared the therapeutic effects of extracorporeal shockwave therapy (ESWT), bisphosphonate (Aclasta), and human Wharton jelly-derived mesenchymal stem cells (WJMSCs) in a rat model of OP.

View Article and Find Full Text PDF

Introduction: Spasticity is a common complication of stroke, which is related to poor motor recovery and limitations in the performance of activities. Both transcranial magnetic stimulation (TMS) and extracorporeal shockwave therapy (ESWT) are effective treatment methods for poststroke spasticity (PSS). However, there is no existing study exploring the safety and effectiveness of TMS combined with ESWT for PSS.

View Article and Find Full Text PDF

Purpose: This study aimed to investigate the efficacy and safety of extracorporeal shock wave therapy (ESWT) over an 8-week period in individuals diagnosed with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) compared to a control group.

Materials And Methods: This prospective, double-blind, placebo-controlled study enrolled 46 participants diagnosed with CP/CPPS, who were randomly assigned to either the treatment group or the control group in a 2:1 ratio. In the treatment group, ESWT was administered at the perineum once a week for 8 weeks.

View Article and Find Full Text PDF
Article Synopsis
  • Patellar tendinopathy, or jumper's knee, is a painful condition affecting athletes, prompting a study to evaluate the effectiveness of platelet-rich plasma (PRP) treatments alone and combined with extracorporeal shockwave therapy (ESWT).
  • The study involved 33 athletes randomly assigned to receive either PRP with sham treatment or PRP plus ESWT, with follow-ups over a year to assess pain reduction and functional improvements.
  • Results indicated that combining PRP with ESWT led to quicker pain relief and improved outcomes without causing discomfort or injury, supporting its effectiveness for treating chronic patellar tendinopathy in athletes.
View Article and Find Full Text PDF

Background: Extracorporeal shock wave therapy (ESWT), as a non-invasive physical agent modality, was effective in relieving spasticity, reducing pain, and improving dysfunction. This systematic review and meta-analysis aimed to investigate the effect of ESWT on nerve conduction, and to find out whether the ESWT group is superior to the control or other comparison groups, thus providing support for guiding the rehabilitation of peripheral nerve injury in clinical work.

Methods: PubMed, Web of Science, the Cochrane Library, and Embase were searched from inception to August 20, 2024.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!